BRPI0918221A2 - vacinas inicial, composta por vesícula de membrana externa, e reforço, composta por proteína. - Google Patents

vacinas inicial, composta por vesícula de membrana externa, e reforço, composta por proteína.

Info

Publication number
BRPI0918221A2
BRPI0918221A2 BRPI0918221A BRPI0918221A BRPI0918221A2 BR PI0918221 A2 BRPI0918221 A2 BR PI0918221A2 BR PI0918221 A BRPI0918221 A BR PI0918221A BR PI0918221 A BRPI0918221 A BR PI0918221A BR PI0918221 A2 BRPI0918221 A2 BR PI0918221A2
Authority
BR
Brazil
Prior art keywords
booster
protein
outer membrane
membrane vesicle
vaccines
Prior art date
Application number
BRPI0918221A
Other languages
English (en)
Inventor
Ian Feavers
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Publication of BRPI0918221A2 publication Critical patent/BRPI0918221A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0918221A 2008-09-05 2009-09-04 vacinas inicial, composta por vesícula de membrana externa, e reforço, composta por proteína. BRPI0918221A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0816284.4A GB0816284D0 (en) 2008-09-05 2008-09-05 Vaccine
PCT/GB2009/002129 WO2010026385A1 (en) 2008-09-05 2009-09-04 Outer membrane vesicle prime - protein boost vaccine

Publications (1)

Publication Number Publication Date
BRPI0918221A2 true BRPI0918221A2 (pt) 2015-12-08

Family

ID=39888899

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918221A BRPI0918221A2 (pt) 2008-09-05 2009-09-04 vacinas inicial, composta por vesícula de membrana externa, e reforço, composta por proteína.

Country Status (10)

Country Link
US (1) US20110262484A1 (pt)
EP (1) EP2341930A1 (pt)
JP (1) JP2012502013A (pt)
CN (1) CN102202686A (pt)
AU (1) AU2009289059A1 (pt)
BR (1) BRPI0918221A2 (pt)
CA (1) CA2736151A1 (pt)
GB (1) GB0816284D0 (pt)
NZ (1) NZ591724A (pt)
WO (1) WO2010026385A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515935A (en) 1999-05-19 2004-01-30 Chiron S Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
US9259462B2 (en) * 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
AU2013276083B2 (en) * 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
JP6283674B2 (ja) 2012-09-18 2018-02-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 外膜小胞
JP6956067B2 (ja) * 2015-08-11 2021-10-27 オービス ヘルス ソリューションズ エルエルシー 細菌およびウイルスのワクチン戦略

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2519440T3 (es) * 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
GB0424092D0 (en) * 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins

Also Published As

Publication number Publication date
NZ591724A (en) 2012-07-27
WO2010026385A1 (en) 2010-03-11
AU2009289059A1 (en) 2010-03-11
JP2012502013A (ja) 2012-01-26
EP2341930A1 (en) 2011-07-13
GB0816284D0 (en) 2008-10-15
CA2736151A1 (en) 2010-03-11
US20110262484A1 (en) 2011-10-27
CN102202686A (zh) 2011-09-28

Similar Documents

Publication Publication Date Title
BRPI0918221A2 (pt) vacinas inicial, composta por vesícula de membrana externa, e reforço, composta por proteína.
BRPI0923158A2 (pt) membrana de polímero microporoso modificada por polímero aquoso, método de produção e uso da mesma.
BR112012004330A2 (pt) compósito, sistema de membrana antimicrobiano, e, usos de um sistema de membrana antimicrobiano e de um material compósito.
BRPI0913268A2 (pt) vacina de vesícula de membrana externa nativa multivalente meningocócica, métodos de fabricação e uso da mesma
BRPI0919657A2 (pt) membrana impermeável.
BRPI0815054A2 (pt) Método e aparelho de speração de membrana.
DK2307543T3 (da) Forbedret proteinekspressionssystem
LTC2358756I2 (lt) Žmogaus antikūnai, pasižymintys dideliu giminingumu pcsk9
BRPI0917250A2 (pt) sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente
BRPI0819714A2 (pt) Formulações de proteína e métodos de produção das mesmas.
BRPI1011801A2 (pt) membranas biométricas e seus usos.
BRPI0922758A2 (pt) instrumento cirúrgico, cabo para instrumento cirúrgico e sistema de instrumento cirúrgico.
BRPI1013068A2 (pt) membrana de pervaporação de cerâmica e membrana de cerâmica permeável ao vapor
EP1993811A4 (en) BIORIENTEE MICROPOROUS MEMBRANE
BRPI0920026A2 (pt) método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.
BRPI0914155A2 (pt) preparações de xampu
EP2306836A4 (en) MODULATORS OF BMI-1 PROTEIN EXPRESSION
IL230076A0 (en) Certain chemical entities, compositions and methods
BRPI0822756A2 (pt) sistema de prótese de válvula cardíaca e processo para produzir prótese de válvula cardíaca.
BR112012004100A2 (pt) membrana de osmose direta
IL243932A0 (en) Certain chemical entities, compositions and methods
BRPI1011760A2 (pt) método para prevenir ou reduzir coagulação no trato gastrointestinal superior de um indivíduo, e, uso de proteína anticoagulante.
BRPI0924832A2 (pt) "bomba de membrana"
BRPI0921970A2 (pt) membrana microporosa e método para sua formação.
BRPI0822633A2 (pt) Desinfetante, e, método de esterilização.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES. PAGAR RESTAURACAO.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2362 DE 12-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25B Requested transfer of rights rejected

Owner name: HEALTH PROTECTION AGENCY (GB)